ADIA Nutrition, Inc. (OTCQB: ADIA), a leader in advanced nutrition and regenerative health solutions, today announced its 3rd ...

Q1-2026 Revenue of $45.2 Million, up 3% Year-over-Year; Adjusted EBITDA of $11.6 Million, representing a Robust 26% Margin of Revenues; Net Income of $4.1 Million, up 4% Year-over-Year ...

Cypherpunk Technologies Inc., (Nasdaq: CYPH) ("Cypherpunk"), today reported financial results for the first quarter ended March 31, 2026. "Since the start of 2026, Cypherpunk has advanced the mission ...

Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...

Haemonetics (NYSE:HAE) reported fiscal fourth-quarter revenue of $346 million, up 5% on a reported basis and 9% organically excluding CSL, as strength in its Plasma and Blood Management ...

Nuo Therapeutics, Inc. (OTCQB: AURX) ("Nuo"), a commercial-stage medical device company focused on developing and marketing regenerative therapies for chronic ...

Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut Takeda Pharmaceutical (NYSE:TAK) reported fiscal 2025 results that management described as solid despite pressure from generic ...

May 11, 2026) - NovaRed Mining Inc. (CSE: NRED) (OTCQB: NREDF) ("NovaRed" or the "Company") is pleased to report results from ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q1 2026 Earnings Call Transcript May 12, 2026 Acurx Pharmaceuticals, Inc. misses ...

Last year, the biohacker documented his trip after taking 5g of magic mushrooms. Afterwards, he admitted he was 'happy to be ...

When comet 3I/ATLAS swept through the inner solar system in late 2025, it gave astronomers something no interstellar visitor ...